(Secondary) solid tumors in thyroid cancer patients treated with the multi-kinase inhibitor sorafenib may present diagnostic challenges

Author(s):
Schneider, T.C.; Kapiteijn, E.; Wezel, T. van; Smit, J.W.A. (0000-0002-6070-4865); Hoeven, J.J.M. van der; Morreau, H.
Published
2016
Publication type
Article / Letter to editor
SorafenibDifferentiated thyroid cancerSquamous cell carcinomaSquamous differentiationClonal divergence
Date issued
2016-01-19
Language
English
Is part of
BMC Cancer
hdl
1887/107955
doi
10.1186/s12885-016-2060-4